Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
Viral Recombination00:57

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

TIPICO X: report of the 10th interactive infectious disease workshop on infectious diseases and vaccines.

Human vaccines & immunotherapeutics·2020
Same author

Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as vaccine candidate.

bioRxiv : the preprint server for biology·2020
Same author

Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing.

Nature·2020
Same author

COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms.

Research square·2020
Same author

Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection.

bioRxiv : the preprint server for biology·2020
Same author

Induction and Evasion of Type-I Interferon Responses during Influenza A Virus Infection.

Cold Spring Harbor perspectives in medicine·2020

関連する実験動画

Updated: May 9, 2026

Expression of Functional Recombinant Hemagglutinin and Neuraminidase Proteins from the Novel H7N9 Influenza Virus Using the Baculovirus Expression System
12:18

Expression of Functional Recombinant Hemagglutinin and Neuraminidase Proteins from the Novel H7N9 Influenza Virus Using the Baculovirus Expression System

Published on: November 6, 2013

H7N9 H7N9 H7N9 H7N9 H7N9 H7N9 H7N9 H7N9 H7N9 H7N9 H7N9 H7N9 H7N9 H7N9 H7N9 H7N9 H7N9 H7N9 H7N9 H7N9

Ron A M Fouchier, Yoshihiro Kawaoka, Carol Cardona

    Science (New York, N.Y.)
    |August 10, 2013
    PubMed
    まとめ

    No abstract available in PubMed .

    さらに関連する動画

    Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses
    08:10

    Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses

    Published on: January 15, 2020

    Preparation of Pseudo-Typed H5 Avian Influenza Viruses with Calcium Phosphate Transfection Method and Measurement of Antibody Neutralizing Activity
    07:15

    Preparation of Pseudo-Typed H5 Avian Influenza Viruses with Calcium Phosphate Transfection Method and Measurement of Antibody Neutralizing Activity

    Published on: November 22, 2021

    関連する実験動画

    Last Updated: May 9, 2026

    Expression of Functional Recombinant Hemagglutinin and Neuraminidase Proteins from the Novel H7N9 Influenza Virus Using the Baculovirus Expression System
    12:18

    Expression of Functional Recombinant Hemagglutinin and Neuraminidase Proteins from the Novel H7N9 Influenza Virus Using the Baculovirus Expression System

    Published on: November 6, 2013

    Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses
    08:10

    Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses

    Published on: January 15, 2020

    Preparation of Pseudo-Typed H5 Avian Influenza Viruses with Calcium Phosphate Transfection Method and Measurement of Antibody Neutralizing Activity
    07:15

    Preparation of Pseudo-Typed H5 Avian Influenza Viruses with Calcium Phosphate Transfection Method and Measurement of Antibody Neutralizing Activity

    Published on: November 22, 2021